Michael H. Carrel, President, CEO, & Director at AtriCure, Inc. (ATRC), sold 1,454 shares at $33.00 ($48K) on 2019-07-31, disclosed to the SEC on 2019-08-02.
Scheduled sale ($48k) by President, CEO, & Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ATRC | SELL | 2021-02-04 | $1.5M | — | Filing → |
| ATRC | SELL | 2021-01-13 | $1.5M | — | Filing → |
| ATRC | SELL | 2020-12-28 | $1.4M | — | Filing → |